Clinical Fellowship Award Program
Building the next generation of amyloidosis physicians.
2027 Application Period is Now Open!
The Amyloidosis Research Consortium (ARC) Clinical Fellowship Program is developing the next generation of leaders in amyloidosis care and research.
The program funds one-year fellowships at leading U.S. and Canadian amyloidosis centers with ️up to 10 fellows funded. The award program focuses on: Clinical Care, Multi-Disciplinary Collaboration, Research Participation, and Health Equity.
This fellowship is an opportunity to broaden expertise, collaborate with top specialists, and make a lasting impact on patient care and outcomes.
Questions? Contact us at clinicalfellowship@arci.org.
Fellowship Recipients 2026-27
Grace O’Dea, MD
Mass General Brigham
Mentors: Hanna Gaggin, MD, Sarah Cuddy, MD
Hamish Scott, MD
Memorial Sloan Kettering
Dr. Hamish Scott completed undergraduate studies in medical research and worked in a basic science laboratory before undertaking medical training at the University of Melbourne and specialist training in hematology. He subsequently completed a Cellular Therapies Fellowship at Peter MacCallum Cancer Centre and has a particular interest in early-phase clinical trials and translational research.
Mentors: Heather Landau, MD, Jennifer Liu, MD, Edgar Jaimes, MD, Jessica Chapman-Lim, PhD
Hamza Naveed, MD
University of Chicago Hospitals and Endeavor Health System
Dr. Naveed, born and raised in Pakistan, completed his medical training there before pursuing residency at the University of Houston/HCA Kingwood program and a hospitalist year at Conroe Medical Center. His passion lies in amyloidosis, cardiomyopathies, and associated cardiac imaging — a rapidly evolving frontier in cardiovascular medicine. Outside of medicine, he enjoys hiking, ice skating, and socializing with friends and family.
Mentor: Nitasha Sarswat, MD
Jasmine Garg, MD
Oregon Health & Science University
Dr. Garg grew up in Portland, Oregon and earned her medical degree at New York Medical College. She completed her residency at Westchester Medical Center. Dr. Garg is interested in multiple areas within cardiology, including cardiac amyloidosis as well as cardiology research. Outside of medicine, she is passionate about running, swimming, hiking and traveling.
Mentor: Ahmad Masri, MD
Leonard Chiu, MD
University of Texas Southwestern Medical Center at Dallas
Dr. Leonard Chiu earned his medical and master’s degrees from Columbia University, where he developed a passion for cardiac amyloidosis while working with Mathew Maurer. He further completed his internal medicine residency at Vanderbilt and is currently a cardiology fellow at UT Southwestern Medical Center. His research interests include identifying biomarkers in heart failure and transthyretin cardiac amyloidosis.
Mentor: Justin Grodin, MD
Muzna Hussain, MD
Northwestern University
Dr. Hussain earned her medical degree from the Royal College of Surgeons in Ireland. She completed a clinical PhD in cardio-oncology and cardiac amyloidosis through the Cleveland Clinic in conjunction with Queen’s University Belfast. She completed internal medicine residency at Geisinger Northeast, followed as a hospitalist at the University of Kentucky. Her academic interests include cardiac amyloidosis, cardio-oncology, heart failure, and advancing multidisciplinary approaches to complex cardiovascular disease.
Mentors: Sanjiv Shah, MD, Ike Okwuosa, MD
Nancy Herrera, MD
Stanford University
Dr. Nancy Herrera-Leaño is a cardiologist originally from Colombia, and completed her medical training, internal medicine residency, and cardiology fellowship at Pontificia Universidad Javeriana in Bogotá, and a Master’s degree in Heart Failure at SEC–Rey Juan Carlos University in Madrid. She is currently a Postdoctoral Scholar at the Stanford Cardiovascular Institute, where her research focuses on computational approaches to early cardiovascular disease detection. Using the Project Baseline Health Study, she has evaluated contemporary echocardiographic guidelines for left ventricular diastolic dysfunction and is developing hybrid Bayesian–machine learning models to improve early detection and risk stratification of heart failure and cardiac amyloidosis. Her work spans echocardiographic reference standards, strain imaging, and AI-based diagnostic algorithms.
Mentors: Kevin Alexander, MD, Michaela Liedtke, MD
Sherif Eltawansey, MD, MPH
Columbia Irving Medical Center
Sherif Eltawansy began his medical education at the Cairo University School of Medicine in Cairo, Egypt. He obtained a Master’s degree at the same university before moving to the US. He graduated from the Internal Medicine Residency program at Monmouth Medical Center in New Jersey in June 2016. He also earned a Master of Public Health degree from the University of Massachusetts Amherst. His numerous publications reflect the breadth of his training and experience, with a major focus on the epidemiology of various cardiovascular diseases and their associations with other medical comorbidities. Sherif lives in Monroe, New Jersey, where he enjoys spending time with his family and kids. He enjoys playing soccer regularly and loves nature activities and wildlife.
Mentors: Mathew Maurer, MD, Eugene Brailovsky, MD, Karan Wats, MD
Fellowship Recipients 2025-26
Antonio Berumen Martinez, MD
Boston Medical Center & Boston University Chobanian & Avedisian School of Medicine
Mentor: Vaishali Sanchorawala, MD
Artrish Jefferson, MD
University of Texas Southwestern Medical Center at Dallas
Mentor: Justin Grodin, MD
Ayesha Hasan, MD
University of Chicago Hospitals and Endeavor Health System
Mentor: Nitasha Sarswat, MD
Nelson Barrera, MD
Columbia Irving Medical Center
Mentors: Mathew Maurer, MD, Karan Wats, MD, Yevgeniy Brailovsky, MD
Nour Beydoun, MD
Northwestern University
Mentors: Sanjiv Shah, MD, Ike S Okwuosa, MD
Sadia Tanami, MD
Oregon Health & Science University
Mentor: Ahmad Masri, MD
Saloni Srivastava, MD
Mass General Brigham
Mentor: Hanna Gaggin, MD
Questions? Contact us at clinicalfellowship@arci.org
This activity is supported by an independent educational grant from AstraZeneca and Ionis Pharmaceuticals.

